# Study of Individuals and Families With Aberrations in DDX41 or Similar Cancer Predisposition Variants

> **NCT07019155** · — · RECRUITING · sponsor: **National Cancer Institute (NCI)** · enrollment: 510 (estimated)

## Conditions studied

- Germline Mutation
- Myelodysplastic Syndromes
- Acute Myeloid Leukemia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07019155
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-24
- **Primary completion:** 2035-06-15
- **Final completion:** 2035-06-15
- **Target enrollment:** 510 (ESTIMATED)
- **Last updated:** 2026-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07019155

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07019155, "Study of Individuals and Families With Aberrations in DDX41 or Similar Cancer Predisposition Variants". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07019155. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*